Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor.

Doberstein K, Milde-Langosch K, Bretz NP, Schirmer U, Harari A, Witzel I, Ben-Arie A, Hubalek M, Müller-Holzner E, Reinold S, Zeimet AG, Altevogt P, Fogel M.

BMC Cancer. 2014 Dec 15;14(1):958. doi: 10.1186/1471-2407-14-958.

PMID:
25510351
[PubMed - in process]
Free PMC Article
2.

Getting the whole picture: adding patient-reported outcomes to adjuvant endocrine treatment evaluation in premenopausal breast cancer patients.

Oberguggenberger A, Goebel G, Beer B, Oberacher H, Meraner V, Sztankay M, Sperner-Unterweger B, Zeimet AG, Marth C, Hubalek M, Holzner B.

Breast J. 2014 Sep-Oct;20(5):555-7. doi: 10.1111/tbj.12323. Epub 2014 Jul 8. No abstract available.

PMID:
25040193
[PubMed - in process]
3.

Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients.

Muendlein A, Hubalek M, Geller-Rhomberg S, Gasser K, Winder T, Drexel H, Decker T, Mueller-Holzner E, Chamson M, Marth C, Lang AH.

Eur J Cancer. 2014 Aug;50(12):2134-41. doi: 10.1016/j.ejca.2014.05.007. Epub 2014 Jun 5.

PMID:
24910416
[PubMed - indexed for MEDLINE]
4.

Structure of the effector-binding domain of deoxyribonucleoside regulator DeoR from Bacillus subtilis.

Škerlová J, Fábry M, Hubálek M, Otwinowski Z, Rezáčová P.

FEBS J. 2014 Sep;281(18):4280-92. doi: 10.1111/febs.12856. Epub 2014 Jun 25.

PMID:
24863636
[PubMed - indexed for MEDLINE]
5.

The vitamin E-binding protein afamin increases in maternal serum during pregnancy.

Hubalek M, Buchner H, Mörtl MG, Schlembach D, Huppertz B, Firulovic B, Köhler W, Hafner E, Dieplinger B, Wildt L, Dieplinger H.

Clin Chim Acta. 2014 Jul 1;434:41-7. doi: 10.1016/j.cca.2014.03.036. Epub 2014 Apr 24.

PMID:
24768783
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2014 Mar 1;20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.

PMID:
24520097
[PubMed - indexed for MEDLINE]
7.

Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.

Hubalek M, Oberguggenberger A, Beer B, Meraner V, Sztankay M, Oberacher H, Schubert B, Wildt L, Seeber B, Giesinger J, Kemmler G, Holzner B, Sperner-Unterweger B.

Clin Breast Cancer. 2014 Aug;14(4):291-6. doi: 10.1016/j.clbc.2013.12.008. Epub 2013 Dec 27.

PMID:
24468298
[PubMed - in process]
8.

Everolimus in postmenopausal, hormone receptor-positive advanced breast cancer: summary and results of an austrian expert panel discussion.

Gnant M, Greil R, Hubalek M, Steger G.

Breast Care (Basel). 2013 Aug;8(4):293-9. doi: 10.1159/000354121. Review.

PMID:
24415983
[PubMed]
Free PMC Article
9.

Axillary Lymph Node Status in Early-Stage Breast Cancer Patients with Sentinel Node Micrometastases (0.2-2 mm).

Bargehr J, Edlinger M, Hubalek M, Marth C, Reitsamer R.

Breast Care (Basel). 2013 Jun;8(3):187-91. doi: 10.1159/000352090.

PMID:
24415968
[PubMed]
Free PMC Article
10.

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).

Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M; Austrian Breast and Colorectal Study Group (ABCSG).

Ann Oncol. 2014 Feb;25(2):366-71. doi: 10.1093/annonc/mdt508. Epub 2013 Dec 16.

PMID:
24347519
[PubMed - in process]
11.

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group.

Lück HJ, Du Bois A, Loibl S, Schrader I, Huober J, Heilmann V, Beckmann M, Stähler A, Jackisch C, Hubalek M, Richter B, Stickeler E, Eidtmann H, Thomssen C, Untch M, Wollschläger K, Schuster T, von Minckwitz G.

Breast Cancer Res Treat. 2013 Jun;139(3):779-87. doi: 10.1007/s10549-013-2589-8. Epub 2013 Jun 15.

PMID:
23771714
[PubMed - indexed for MEDLINE]
12.

Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk.

De Araujo ME, Erhart G, Buck K, Müller-Holzner E, Hubalek M, Fiegl H, Campa D, Canzian F, Eilber U, Chang-Claude J, Coassin S, Haun M, Kedenko L, Paulweber B, Reitsamer R, Himmel I, Flesch-Janys D, Lamina C, Kronenberg F, Huber LA, Kloss-Brandstätter A.

PLoS One. 2013;8(1):e53768. doi: 10.1371/journal.pone.0053768. Epub 2013 Jan 16.

PMID:
23341997
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer.

Muendlein A, Lang AH, Geller-Rhomberg S, Winder T, Gasser K, Drexel H, Decker T, Mueller-Holzner E, Chamson M, Marth C, Hubalek M.

J Cancer Res Clin Oncol. 2013 Mar;139(3):491-8. doi: 10.1007/s00432-012-1355-3. Epub 2012 Nov 23.

PMID:
23180020
[PubMed - indexed for MEDLINE]
14.

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.

Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H, Kemmler G, Giesinger J, Gamper E, Sperner-Unterweger B, Marth C, Holzner B, Hubalek M.

BMC Cancer. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474.

PMID:
23066928
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer.

Petru E, Zeimet AG, Sevelda P, Seifert M, Singer C, Hubalek M, Angleitner-Boubenizek L, Speiser P, Benedicic C, Stummvoll W, Reinthaller A; Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO).

Wien Klin Wochenschr. 2012 Jun;124(11-12):412-8. doi: 10.1007/s00508-012-0185-2. Epub 2012 Jun 28. Erratum in: Wien Klin Wochenschr. 2012 Sep;124(17-18):669. Singer, Christian [added].

PMID:
22739650
[PubMed - indexed for MEDLINE]
16.

[Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].

Singer CF, Tea MK, Pristauz G, Hubalek M, Rappaport C, Riedl C, Helbich T.

Wien Klin Wochenschr. 2012 May;124(9-10):334-9. doi: 10.1007/s00508-012-0173-6. Epub 2012 May 28. German. Erratum in: Wien Klin Wochenschr. 2012 Oct;124(19-20):735.

PMID:
22644217
[PubMed - indexed for MEDLINE]
17.

HE4 is an independent prognostic marker in endometrial cancer patients.

Mutz-Dehbalaie I, Egle D, Fessler S, Hubalek M, Fiegl H, Marth C, Widschwendter A.

Gynecol Oncol. 2012 Aug;126(2):186-91. doi: 10.1016/j.ygyno.2012.04.022. Epub 2012 Apr 21.

PMID:
22525819
[PubMed - indexed for MEDLINE]
18.

Evaluation of sample preparation methods for MALDI-TOF MS identification of highly dangerous bacteria.

Drevinek M, Dresler J, Klimentova J, Pisa L, Hubalek M.

Lett Appl Microbiol. 2012 Jul;55(1):40-6. doi: 10.1111/j.1472-765X.2012.03255.x. Epub 2012 May 10.

PMID:
22512320
[PubMed - indexed for MEDLINE]
19.

Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference.

Hubalek M, Bartsch R, Gnant M, Kapp KS, Lang A, Lax S, Lukas P, Neunteufel W, Pristauz G, Reitsamer R, Sandbichler P, Schrenk P, Singer C, Tamussino K, Tschmelitsch J, Zeimet AG, Marth C.

Geburtshilfe Frauenheilkd. 2012 Apr;72(4):293-298.

PMID:
25284834
[PubMed]
Free PMC Article
20.

Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.

Finkenstedt A, Widschwendter A, Brasse-Lagnel CG, Theurl I, Hubalek M, Dieplinger H, Tselepis C, Ward DG, Vogel W, Zoller H.

Blood Cells Mol Dis. 2012 Apr 15;48(4):233-7. doi: 10.1016/j.bcmd.2012.02.001. Epub 2012 Feb 25.

PMID:
22365732
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk